COVID-19

People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.

A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.

Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.

Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

People with mild to moderate COVID-19 can shed viral RNA in their feces months after initial infection, Stanford researchers find. Those who do often have nausea, vomiting and abdominal pain.

Using household items, Stanford students have developed a way to make affordable nasal drops with the potential to slow the spread of viruses like COVID-19.

Two-dose COVID-19 vaccines significantly increase protection against hospitalization and death in people who had the illness before they were immunized.

Stanford Medicine scientists explain what we know, and what we don’t know, about living with COVID-19 two years after the World Health Organization declared a pandemic.

Stanford Medicine’s clinical virology laboratory has processed its 1 millionth COVID-19 test nearly two years after becoming one of the first academic center testing sites in the country.